Key Details
Price
$59.96Last Dividend
$0.67Annual ROE
11.24%Beta
0.45Events Calendar
Next earnings date:
Feb 07, 2025Recent quarterly earnings:
Nov 06, 2024Recent annual earnings:
Feb 07, 2024Next ex-dividend date:
N/ARecent ex-dividend date:
Oct 21, 2024Next split:
N/ARecent split:
June 07, 2005Analyst ratings
Recent major analysts updates
Market Data
Dividend
Profitability
Efficiency
Valuation
Liquidity
Cash Flow
Institutional Ownership
Lately, users of Zacks.com have been focusing on CVS Health (CVS). This interest prompts a closer look at what the stock might offer.
Israel "Izzy" Englander's wealth exceeds $14 billion, so he doesn't rely on dividend income.
Investors frequently depend on the advice of Wall Street analysts to make choices about buying, selling, or holding stocks. When these analysts, who work for brokerage firms, change their ratings, it can significantly influence a stock's price. Media coverage of these changes often plays a role in this impact.
CVS Health Corporation (NYSE:CVS) will participate in the Wolfe 2024 Healthcare Results Conference on November 19, 2024, at 10:20 AM ET. Tom Cowhey, the Executive Vice President and Chief Financial Officer, will be present, while Justin Lake from Wolfe Research will also join the call. Justin acknowledged Larry McGrath, the head of strategy in Investor Relations, for his valuable contributions to the company, even though he chose not to join them on stage.
David Faber from CNBC shares updates about CVS.
On Monday, CVS Health announced that it will add four new members to its board from Glenview Capital Management, a hedge fund that has been advocating for changes at the large healthcare company.
CVS Health made an agreement with the activist investor Glenview Capital, allowing them four seats on the board. Glenview had been advocating for changes within the healthcare company and had discussions with the previous CEO, Karen Lynch, before she was removed.
CVS Health Corp (NYSE:CVS) saw a rise in pre-market trading after revealing that it has added four new board members due to an agreement with activist investor Glenview Capital Management. Larry Robbins, the CEO of the hedge fund, will be joining the board along with Leslie Norwalk, Guy Sansone, and Doug Shulman, bringing the total number of directors to 16.
On Monday, CVS Health announced that it will welcome four new members to its board as part of a deal with Glenview Capital Management, which includes the hedge fund's CEO, Larry Robbins.
CVS Health's Board of Directors has added four new members: Leslie Norwalk, Larry Robbins, Guy Sansone, and Doug Shulman. These appointments come after successful talks with Glenview Capital Management. The announcement was made on November 18, 2024, in Woonsocket, Rhode Island.
FAQ
- What is the primary business of CVS Health?
- What is the ticker symbol for CVS Health?
- Does CVS Health pay dividends?
- What sector is CVS Health in?
- What industry is CVS Health in?
- What country is CVS Health based in?
- When did CVS Health go public?
- Is CVS Health in the S&P 500?
- Is CVS Health in the NASDAQ 100?
- Is CVS Health in the Dow Jones?
- When was CVS Health's last earnings report?
- When does CVS Health report earnings?
- Should I buy CVS Health stock now?